The FDA's Tala Fakhouri discusses the agency's approach to the regulation of AI in clinical trials in a new interview.

A number of recent clinical trials have suggested that gene therapy could help treat diseases of the eye that cause vision ...

The SEC concluded that Cassava Sciences falsified data in its Alzheimer’s clinical trials. Now the FDA needs to act, ...

More research on clinical meaningfulness is on the way, according to Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the ...

The first subject has successfully completed the full 6-month treatment course and clinical visits, marking an important step ...

Can gamified interventions help fight the youth mental health crisis? A new report from Johns Hopkins researchers says yes ...

Researchers have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer. Scientists at the University of Oxford are designing OvarianVax, a vaccine ...

Certain arm positions -- supported on a lap or hanging by the side of the body -- led to significant overestimation of blood pressure readings compared with standardized positioning, a randomized ...

UCSF officially broke ground on the Barbara and Gerson Bakar Research and Academic Building on Sept. 28, which will house state-of-the-art research facilities, and will also serve as the new home for ...

Indications that the GLP-1 drug has greater benefits in the most frail patients should be viewed cautiously, one expert says.

Genentech announced positive results from the Phase III study (REGENCY) of Gazyva (Obinutuzumab) for people with active lupus nephritis (LN).

Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabineResults from this Phase 2 trial will evaluate ...